搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Yahoo
2 天
Understanding your thyroid, the master of metabolism
Thyroid disease is a common condition which can affect people of all ages. By understanding the symptoms, diagnosis and ...
Medscape
3 天
Should Patients With Thyroid Issues Take GLP-1s? It Depends
Obesity and family practice experts share when it’s safe to prescribe GLP-1 receptor agonists to patients with thyroid ...
ABP Live on MSN
11 天
What Causes Thyroid Disorders? Know Symptoms, Tests, And Importance Of Early Diagnosis
Thyroid disorders occur when the thyroid gland malfunctions, causing symptoms like fatigue, weight gain, anxiety, heart rate ...
STAT
6 天
Viridian confirms benefit of drug for thyroid eye disease
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Medical News Today
13 天
What is Graves' disease?
Graves’ disease is an autoimmune condition that causes the thyroid gland to overproduce thyroid hormones. Treatment for Graves’ disease is relatively simple, but without it, the disease can ...
ophthalmologytimes
4 天
Viridian announces topline data from THRIVE-2 phase 3 clinical trial of veligrotug for ...
THRIVE-2 met all primary and secondary endpoints at the 15-week primary analysis timepoint after 5 infusions of veligrotug.
6 天
Viridian Therapeutics: Promising THRIVE-2 Study Results Position Veligrotug as a Market ...
H.C. Wainwright analyst Douglas Tsao has reiterated their bullish stance on VRDN stock, giving a Buy rating today.Pick the best stocks and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈